Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and

Sarah Leatherman1,2, Ryan Ferguson1,3, Cynthia Hau1

  • 1VA Boston Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Boston, MA, United States.

Insights

Elevated triglycerides (TG) in patients with controlled LDL-C on statins showed a modest increase in cardiovascular events, particularly in those with diabetes or prior cardiovascular disease. This highlights residual risk in high-risk populations.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Epidemiology

Background:

  • Recent studies indicate elevated triglycerides (TG) play a causal role in incident cardiovascular (CV) events.
  • This risk is particularly pronounced in patients with diabetes and established coronary heart disease (CHD).

Purpose of the Study:

  • To explore residual CV risk in U.S. veterans with statin-controlled LDL-C but elevated baseline TG levels.
  • To compare composite CV event rates between elevated TG and normal TG groups stratified by CV risk.

Main Methods:

  • A cohort of 396,189 U.S. veterans on statins but not TG-lowering agents was analyzed (2010-2015).
  • Composite CV event rates were compared between elevated (150-499 mg/dL) and normal (<150 mg/dL) TG groups.
  • Analysis was stratified by diabetes status and prior CV events.

Main Results:

  • 28% of the cohort had elevated TG levels.
  • Overall, elevated TG was associated with a modest increase in CV events (adjusted rate ratio 1.05).
  • This association was significant in patients with diabetes (1.05) and prior CV events (1.07), but not in those without diabetes or prior events (0.99).

Conclusions:

  • Elevated TG levels in patients with well-controlled LDL-C on statins are associated with a modest increase in residual CV events.
  • The risk is more pronounced in patients with diabetes or established CV disease.
  • Elevated TG contributes to residual CV risk in both high-risk primary and secondary prevention settings.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
752
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
219
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
635
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16